Evidence map›Paper›PMID 17210790›Full record

ArticleGenes & development2007

MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development.

Paul L Boutz, Geetanjali Chawla, Peter Stoilov, Douglas L Black

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Genes & development, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01911091 (Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue), which is not on this map. Cited by 150 papers.

0numbers the graph read from it
0cells of the map it votes in
150citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01911091 naactive not recruitingnot on this mapstarted 2013, after this paper: background citation

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue

TypeinterventionalSponsorAdventHealth Translational Research InstituteRan2013 to 2026Enrolled56ConditionsObesity, Disorder of Lipid Storage and Metabolism, Lipid Metabolism Disorders, Metabolic DisorderArmsExercise
3 · Its place in the literature

Who cites it

150 citing papers in PubMed, 301 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. From development to disease: the neuronal role of hnRNPs through the lens ofFrontiers in cell and developmental biology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. miRNA-Based Regulation of Alternative RNA Splicing in Metazoans.International journal of molecular sciences · 2021
    Review
  19. Frontiers in neuroscience · 2021
    Article
  20. Review

90 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Paul L BoutzDepartment of Microbiology, Immunology, and Molecular Genetics, University of California at Los Angeles, Los Angeles, California 90095, USA.
Geetanjali Chawla
Peter Stoilov
Douglas L Black
University of California, Los Angeles · USHoward Hughes Medical Institute · US

Funding

The Regulation of Neuronal Exon SplicingR01GM049662 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BLACK, DOUGLAS L · 1998 to 2019
$6.5M
NIGMS NIH HHS R01 GM049662NIGMS NIH HHS R01 GM49662
6 · The paper itself

Abstract

Alternative pre-mRNA splicing determines many changes in gene expression during development. Two regulators known to control splicing patterns during neuron and muscle differentiation are the polypyrimidine tract-binding protein (PTB) and its neuronal homolog nPTB. These proteins repress certain exons in early myoblasts, but upon differentiation of mature myotubes PTB/nPTB expression is reduced, leading to increased inclusion of their target exons. We show here that the repression of nPTB expression during myoblast differentiation results from its targeting by the muscle-restricted microRNA miR-133. During differentiation of C2C12 myoblasts, nPTB protein but not mRNA expression is strongly reduced, concurrent with the up-regulation of miR-133 and the induction of splicing for several PTB-repressed exons. Introduction of synthetic miR-133 into undifferentiated C2C12 cells leads to a decrease in endogenous nPTB expression. Both the miR-133 and the coexpressed miR-1/206 microRNAs are extremely conserved across animal species, and PTB proteins are predicted targets for these miRNAs in Drosophila, mice, and humans. There are two potential miR-133-responsive elements (MRE) within the nPTB 3' untranslated region (UTR), and a luciferase reporter carrying this 3' UTR is repressed by miR-133 in an MRE-dependent manner. Transfection of locked nucleic acid (LNA) oligonucleotides designed to block the function of miR-133 and miR-1/206 increases expression of nPTB and decreases the inclusion of PTB dependent exons. These results indicate that miR-133 directly down-regulates a key splicing factor during muscle development and establishes a role for microRNAs in the control of a developmentally dynamic splicing program.

Indexed as

Alternative SplicingGene Expression Regulation, DevelopmentalMuscle Development3' Untranslated RegionsAnimalsBlotting, NorthernBlotting, WesternCell DifferentiationCells, CulturedDrosophilaGene TargetingHumansLuciferasesMiceMicroRNAsMuscles3' Untranslated Regionslocked nucleic acidLuciferasesMicroRNAsOligonucleotidesOligonucleotides, AntisensePolypyrimidine Tract-Binding ProteinRNA, Small Interfering

Identifiers

PMID17210790
PMCPMC1759902
OpenAlexW2166118364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.